Philip Morris's revenue misses estimates as cigarette volumes drop

Philip Morris International shares dropped approximately 7% after the company missed second-quarter revenue expectations, with total sales of $10.14 billion falling short of estimates due to disappointing ZYN nicotine pouch shipments of 190 million cans against an expected 203 million. Despite this ZYN miss and high investor expectations, PMI raised its full-year profit guidance, attributing the improved outlook to strong performance in its IQOS heated tobacco products and resilient cigarette sales, reinforcing its strategic transition to smoking alternatives.

Analysis

Philip Morris International (PMI) experienced a significant share price decline of approximately 7% following its second-quarter report, which presented a conflicting picture of operational performance versus market expectations. The primary catalyst for the negative market reaction was the company's failure to meet revenue consensus, posting $10.14 billion against an anticipated $10.33 billion. This miss was directly attributed to disappointing shipment volumes for its key growth product, ZYN nicotine pouches, which came in at 190 million cans, well below the 203 million expected by analysts. The shortfall highlights the high investor expectations priced into the stock, as noted by Bernstein, where strong underlying growth of 23.8% in the nicotine pouch business was still perceived as insufficient. Despite the ZYN-related revenue miss, PMI demonstrated underlying financial strength by beating adjusted profit estimates with $1.95 per share versus an expected $1.86. Furthermore, management raised its full-year adjusted profit guidance to a range of $7.43 to $7.56 per share, citing steady growth in its IQOS heated tobacco products and a resilient performance in its legacy cigarette business. This suggests that while the market is intensely focused on ZYN's growth trajectory, the company's diversified portfolio provides a robust foundation for profitability.

Key Decisions for Investors

• Investors should assess whether the 7% share price drop, driven by a ZYN shipment miss, represents a buying opportunity, given that the company beat profit estimates and raised full-year guidance.
• Closely monitor future ZYN shipment volumes and U.S. market share data, as these metrics have become the primary driver of short-term sentiment and a return to exceeding expectations could serve as a major catalyst.
• Acknowledge the fundamental strength provided by the IQOS and resilient combustible segments, which underpin the company's profitability and may offer a buffer against moderated growth in the nicotine pouch category.
• Consider the competitive landscape, particularly relative to British American Tobacco's Velo, as PMI's ability to execute on its strategy to make ZYN the global category leader is central to the long-term investment thesis.